Status:
UNKNOWN
Sensitivity of Targeted Biopsy Within Sydney Protocol for GIM
Lead Sponsor:
King Chulalongkorn Memorial Hospital
Conditions:
Intestinal Metaplasia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Sensitivity of Targeted Biopsy Within Sydney Protocol by Using Narrow Band Imaging for Extensive Gastric Intestinal Metaplasia Diagnosis Objective: The aim of this study is to evaluate the sensitivi...
Detailed Description
Background and Rationale: Gastric cancer has been in the top-5 of cancer-related death worldwide. Early detection by screening program in high risk patients is very important. If we can detect pre-ma...
Eligibility Criteria
Inclusion
- At least 18 year of age
- Suspected GIM by previous tissue pathology
- Able to provide informed consent for participation
Exclusion
- Previous gastric surgery including gastrectomy and bypass surgery
- Coagulopathy
- Pregnancy
- Active upper GI bleeding
Key Trial Info
Start Date :
November 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2021
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT04331951
Start Date
November 1 2019
End Date
October 31 2021
Last Update
April 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King Chulalongkorn Memorial Hospital
Bangkok, Thailand, 10330